跳至主要内容
临床试验/CTRI/2024/04/065476
CTRI/2024/04/065476尚未招募不适用

A retrospective, multicenter, observational, real-world post-market clinical follow-up study to evaluate the safety and performance of MEGASORBâ„¢ surgical suture used for general soft tissue approximation and/or ligation, including use in ophthalmic surgery

Meril Life Sciences Pvt Ltd2 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2024年4月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
260
试验地点
2
主要终点
1. Wound disruptions

研究概览

简要总结

MEGASORBSURGICAL SUTURE PMCF STUDY: A retrospective, multicenter, observational, real-world post-market clinical follow-up study to evaluate the safety and performance of MEGASORBâ„¢ surgical suture used for general soft tissue approximation and/or ligation, including use in ophthalmic surgery

Study Design: A retrospective, multicenter, observational, real-world postmarket clinical follow-up study

Patient Population: All consecutive patients who underwent surgical experience like general soft tissue approximation and/or ligation, including use in ophthalmic surgery using MEGASORBâ„¢ Surgical suture, and have completed a minimum of 3-month follow-up.

Objective: To evaluate the safety and performance of MEGASORBâ„¢ surgical suture used for general soft tissue approximation and/or ligation, including use in ophthalmic surgery cutting in realworld patients.

研究设计

研究类型
Observational

入排标准

年龄范围
4.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All consecutive patients who underwent surgical experience like general soft tissue approximation and/or ligation, including use in ophthalmic surgery using MEGASORBâ„¢ Surgical suture.
  • Patients who have completed a minimum of 03 month after the surgery using MEGASORBâ„¢ surgical suture.

排除标准

  • Since this is a retrospective review of data, there are no specific exclusion Criteria.

结局指标

主要结局

1. Wound disruptions

时间窗: 1. Time frame: Discharge, through 7 days, through 30 days | 2. Time Frame: Pre-operative, | postoperative, through 7 days, through 30 days | 3. Time Frame: During | Procedure | 4. Time Frame: Discharge, | through 7 days, through 30 days | 5. Time Frame: Intra-operative

2. Intraocular Pressure (IOP) following hypotonyrelated complications

时间窗: 1. Time frame: Discharge, through 7 days, through 30 days | 2. Time Frame: Pre-operative, | postoperative, through 7 days, through 30 days | 3. Time Frame: During | Procedure | 4. Time Frame: Discharge, | through 7 days, through 30 days | 5. Time Frame: Intra-operative

3. Intra-operative complication

时间窗: 1. Time frame: Discharge, through 7 days, through 30 days | 2. Time Frame: Pre-operative, | postoperative, through 7 days, through 30 days | 3. Time Frame: During | Procedure | 4. Time Frame: Discharge, | through 7 days, through 30 days | 5. Time Frame: Intra-operative

4. Surgical Site Infection

时间窗: 1. Time frame: Discharge, through 7 days, through 30 days | 2. Time Frame: Pre-operative, | postoperative, through 7 days, through 30 days | 3. Time Frame: During | Procedure | 4. Time Frame: Discharge, | through 7 days, through 30 days | 5. Time Frame: Intra-operative

5. Time to wound closure

时间窗: 1. Time frame: Discharge, through 7 days, through 30 days | 2. Time Frame: Pre-operative, | postoperative, through 7 days, through 30 days | 3. Time Frame: During | Procedure | 4. Time Frame: Discharge, | through 7 days, through 30 days | 5. Time Frame: Intra-operative

次要结局

  • 1. Wound healing(2. Length of hospital stay)

研究者

发起方
Meril Life Sciences Pvt Ltd
申办方类型
Other [Medical Device Company ]
责任方
Principal Investigator
主要研究者

Dr Kirankumar Shetty

Meril Life Sciences Pvt. Ltd

研究点 (2)

Loading locations...

相似试验